Neurologic - argenx

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05988073

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy

Drug

Botulinum toxin type A

Phase

Observational

Condition

Multifocal Motor Neuropathy, MMN

Keywords

Multifocal Motor Neuropathy | MMN